Praxis Precision Medicines (PRAX) Shares Outstanding (2019 - 2026)

Praxis Precision Medicines has reported Shares Outstanding for 8 years, with the latest figure at $27.9 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 36.96% year-over-year to $27.9 million; the trailing twelve-month figure through Mar 2026 stood at $27.9 million (up 36.96% YoY), and the FY2025 full-year result was $25.2 million, up 29.72% from the prior year.
• Shares Outstanding for Q1 2026 stood at $27.9 million, up from $25.2 million in the prior quarter.
• The five-year high for Shares Outstanding was $27.9 million in Q1 2026, with the low at $3.0 million in Q1 2022.
• Average Shares Outstanding over 5 years is $13.3 million, with a median of $13.3 million recorded in 2024.
• Year-over-year, Shares Outstanding plunged 93.2% in 2022 and soared 243.11% in 2024.
• Tracing PRAX's Shares Outstanding over 5 years: stood at $3.3 million in 2022, then surged by 167.05% to $8.8 million in 2023, then surged by 120.91% to $19.4 million in 2024, then climbed by 29.72% to $25.2 million in 2025, then increased by 10.58% to $27.9 million in 2026.
• The last three Shares Outstanding figures came in at $27.9 million (Q1 2026), $25.2 million (Q4 2025), and $21.2 million (Q3 2025), per Business Quant data.

Peer Comparison